← Open Payments lookup

ADONIS AL-BOTROS: Open Payments

NPI 1316994551 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,217 in 191 payments from 18 companies in 2025. Trend: 2023 $12,029 · 2024 $6,744 · 2025 $3,217

Food & beverage: $3,008Education: $209
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.26$632
Alkermes, Inc.15$316
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)23$309
ABBVIE INC.28$268
Otsuka America Pharmaceutical, Inc.16$230
Vanda Pharmaceuticals Inc.13$226
Neurocrine BioSciences, Inc.18$225
Bausch Health US, LLC11$223
Janssen Pharmaceuticals, Inc12$197
Axsome Therapeutics, Inc.8$181

Products named: CAPLYTA, ARISTADA, VRAYLAR, FANAPT, INGREZZA, REXULTI, UZEDY, AUSTEDO XR.

Industry payments across OK — which companies pay providers there.